20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Exploring DSIP: A New Avenue for Pain Relief & Analgesic Compound Development

The search for effective and non-addictive pain relief strategies remains a paramount challenge in modern medicine. As the opioid crisis highlights the need for safer alternatives, researchers are turning to naturally occurring compounds with analgesic properties. Delta Sleep Inducing Peptide (DSIP) has emerged as a compelling subject in this quest, demonstrating significant promise for pain relief & analgesic compound development.

DSIP has been shown to possess potent antinociceptive action, meaning it can reduce the sensation of pain. Intriguingly, this effect is often blocked by naloxone, suggesting an interaction with opioid receptors. This mechanism offers a fascinating pathway for developing new pain therapies that might modulate endogenous opioid systems without the severe side effects associated with traditional opioids. Laboratories deeply invested in DSIP for pain management research are keenly exploring these interactions.

The potential for DSIP in treating chronic pain conditions has been explored in clinical pilot studies, showing therapeutic effects in patients experiencing pronounced pain episodes. Unlike conventional analgesics, DSIP's action may involve restoring physiological balance and improving stress tolerance, which are often contributing factors to chronic pain. For those looking to buy DSIP for pain relief studies, NINGBO INNO PHARMCHEM CO.,LTD. offers a reliable supply of high-purity DSIP peptide.

Furthermore, DSIP's unique properties extend to its ability to inhibit the development of opioid dependence, making it a valuable subject for research into addiction recovery, particularly in opioid withdrawal treatment DSIP. This dual action – both pain relief and potential anti-addictive properties – positions DSIP as a truly innovative compound for the future of pain management. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting this vital research by providing superior quality analgesic DSIP peptide. By investing in DSIP research, we can collectively work towards a future where effective pain relief is accessible and safe for all.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: DSIP: A Promising Horizon for Pharmaceutical Innovations in Neurological Disorders

Next: Terlipressin: A Lifesaving Peptide in Managing Acute Gastrointestinal Bleeding

All Rights Reserved